Study to Evaluate the Feasibility of Syde® Digital Endpoints for Monitoring Patients With Progressive Supranuclear Palsy - Richardson Syndrome (PSP-R)

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSYSNAV

About this trial

The study aims to assess the feasibility/acceptability of real-world activity monitoring by the Syde® wearable device in PSP-R. The Syde® collected data will be compared to on-site conventional clinical endpoints, including functional capacity and cognitive assessments, as well as core scales assessments.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

Patients with extreme cognitive disorders that limit their understanding of the data collection process (training of device use and 4-week recording periods every 4 months, device return at the end of the study), tests to be performed including eye movement recording (every 8 months), the implication of the study and consent.

Patients who do not tolerate to keep the sensors on their ankles.

Patients who have undergone a surgical procedure or who have experienced recent trauma (within fewer than 6 months) affecting the lower limbs.

A concomitant chronic or acute neurological, endocrine, infectious, allergic, or inflammatory pathology within the 3-week period immediately prior to inclusion.

Trial population

Patients With Progressive Supranuclear Palsy - Richardson Syndrome (PSP-R)

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Number of patients reaching the optimal threshold of recordings during the recording periods defined in the protocol.

Number of patients reaching the optimal threshold of recordings during the recording periods defined in the protocol (supposed optimal threshold for analysis) at baseline, Month 4, Month 8, Month 12 and Month 16.

Time frame
16 months
2

French Usability score (F-SUS) at Month 4 and at the end of the study

Usability score at Month 4 and Month 16. The System Usability Scale is a 10-item questionnaire . It is a simple tool to measure the usability of an interactive system and it is widely used. For each item, the user is asked to express their level of agreement or disagreement from 1 (strongly disagree) and 5 (strongly agree).

Time frame
16 months

Secondary outcomes

1

Change from baseline in the total wearing time at months 4, 8, 12, and 16.

Change from baseline in the total wearing time at months 4, 8, 12, and 16.

Time frame
16 months
2

Reproducibility of Syde® digital endpoints for each recording period timepoint

Reproducibility of Syde® digital endpoints assessed by the ICC (Intra-Class Correlation) and Bland and Altman analysis for each recording period timepoint (baseline, 4 months, 8 months, 12 months, and 16 months)

Time frame
16 months
3

Correlation between Syde® digital endpoints and 2-minute walk test (2MWT)

Correlation at baseline and at different timepoints between Syde® digital endpoints and 2MWT

Time frame
16 months
4

Correlation between Syde® digital endpoints and 10-meter walk test (10MWT)

Correlation at baseline and at different timepoints between Syde® digital endpoints and 10MWT

Time frame
16 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: